Polaryx Therapeutics, Inc.
PLYXNASDAQHealthcareBiotechnology
As of Oct 23, 2026 close
- Market cap
- $89.31M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $1.83$48.91
- Volume (live)
- -
- Avg. volume (3M)
- 30.80K
Polaryx Therapeutics (PLYX) Stock Price & Financial Analysis
Polaryx Therapeutics Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $1.84 - $1.90 |
|---|---|
| 52-Week High | $48.91 |
| 52-Week Low | $1.83 |
| Open | $1.90 |
| Volume (last close) | 43.03K |
| Average Volume (3M) | 30.80K |
| 50-Day MA | $2.07 |
|---|
| Market Cap | 89.31M |
|---|---|
| Shares Outstanding | 48.28M |
| Price to Book (P/B) | 8.16 |
| EV/EBITDA | -14.46 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
Source: Market prices and company fundamentals. Data as of Oct 23, 2026. Data sources and methodology
Polaryx Therapeutics at a Glance
As of the Oct 23, 2026 close, Polaryx Therapeutics (PLYX) has a market capitalization of $89.31M.
As of its latest reported balance sheet, it holds $11.54M in cash and securities against $0.00 of debt, a net cash position of $11.54M.
Polaryx Therapeutics does not currently pay a dividend.
At $1.85 (the Oct 23, 2026 close) it sits near the bottom of its 52-week range of $1.83 to $48.91.
Frequently Asked Questions About Polaryx Therapeutics
What is the current stock price for PLYX?
As of the Oct 23, 2026 close, PLYX stock trades at $1.85. The 52-week range is $1.83–$48.91, with a day range of $1.84–$1.90.
What is the P/E ratio for PLYX?
The P/E ratio (Price-to-Earnings) for PLYX is shown in the Key Statistics section. This valuation metric helps compare Polaryx Therapeutics, Inc. to industry peers.
Does PLYX pay dividends?
Polaryx Therapeutics does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for PLYX?
Analyst ratings and recommendations for PLYX are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.
What is the market cap of PLYX?
As of the Oct 23, 2026 close, Polaryx Therapeutics's market capitalization is $89.3M, classifying it as a micro-cap company. Polaryx Therapeutics operates in the Healthcare sector within the Biotechnology industry.